Transgenic Mice Aberrantly Expressing Pyruvate Dehydrogenase Complex E2 Component on Biliary Epithelial Cells Do Not Show Primary Biliary Cirrhosis

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2006 Jun 24

PMID 16792678

Citations 7

Authors

K Inamura

H Tsuji

Y Nakamoto

M Suzuki

S Kaneko

Affiliations

Soon will be listed here.

Abstract

Primary biliary cirrhosis (PBC) is an autoimmune disorder that specifically destroys biliary epithelial cells (BECs). In patients with PBC, the immunodominant pyruvate dehydrogenase complex E2 component (PDC-E2), identified as an antigen for disease-specific anti-mitochondrial antibody, is expressed aberrantly in the BEC cytoplasm. The present study focused on the pathophysiological role of aberrant PDC-E2 in the development of PBC. The BEC-specific cytokeratin-19 promoter and PDC-E2 gene were cloned from a mouse cDNA library. The constructed transgene was microinjected into fertilized eggs of mice, and the offspring were identified by Southern blotting and reverse transcriptase-polymerase chain reaction. The protein expression was confirmed by immunoprecipitation, immunoblotting and immunohistochemical staining. Five founder lines were identified as carrying the PDC-E2 gene, and one of these lines expressed PDC-E2 mRNA. The protein expression of exogenous PDC-E2 was detected in the liver. The transgenic mouse line showed diffuse expression of PDC-E2 in the BEC cytoplasm. Biochemical, serological and histological features of PBC were not detected. We established transgenic mice that constitutively express PDC-E2. The results indicated that aberrant PDC-E2 expression in the cytoplasm of BECs is not sufficient for the initiation of autoimmunity. Additional factors may be required to establish a model of PBC.

Citing Articles

Evaluation of Inhibitory Antibodies against the Muscarinic Acetylcholine Receptor Type 3 in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.

Wilde A, Greverath L, Steinhagen L, de Chamorro N, Leicht E, Fischer J J Clin Med. 2022; 11(3).

PMID: 35160133 PMC: 8836427. DOI: 10.3390/jcm11030681.

Primary biliary cirrhosis: From bench to bedside.

Kouroumalis E, Notas G World J Gastrointest Pharmacol Ther. 2015; 6(3):32-58.

PMID: 26261733 PMC: 4526840. DOI: 10.4292/wjgpt.v6.i3.32.

Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.

Trivedi P, Cullen S Hepatol Int. 2015; 7(1):28-47.

PMID: 26201620 DOI: 10.1007/s12072-012-9362-7.

Mechanisms of tissue injury in autoimmune liver diseases.

Liaskou E, Hirschfield G, Gershwin M Semin Immunopathol. 2014; 36(5):553-68.

PMID: 25082647 DOI: 10.1007/s00281-014-0439-3.

Role of autoimmunity in primary biliary cirrhosis.

Shi T, Zhang F World J Gastroenterol. 2013; 18(48):7141-8.

PMID: 23326118 PMC: 3544015. DOI: 10.3748/wjg.v18.i48.7141.

References

Shimoda S, Nakamura M, Shigematsu H, Tanimoto H, Gushima T, Gershwin M . Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis. Hepatology. 2000; 31(6):1212-6. DOI: 10.1053/jhep.2000.8090. View

Potter K, Thomson R, Hamblin A, Richards S, Lindsay J, Stevenson F . Immunogenetic analysis reveals that epitope shifting occurs during B-cell affinity maturation in primary biliary cirrhosis. J Mol Biol. 2001; 306(1):37-46. DOI: 10.1006/jmbi.2000.4210. View

Migliaccio C, Van de Water J, Ansari A, KAPLAN M, Coppel R, Lam K . Heterogeneous response of antimitochondrial autoantibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2: the molecule versus the mimic. Hepatology. 2001; 33(4):792-801. DOI: 10.1053/jhep.2001.23783. View

Odin J, Huebert R, Casciola-Rosen L, Larusso N, Rosen A . Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest. 2001; 108(2):223-32. PMC: 203018. DOI: 10.1172/JCI10716. View

Long S, Quan C, Van de Water J, Nantz M, Kurth M, BARSKY D . Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol. 2001; 167(5):2956-63. DOI: 10.4049/jimmunol.167.5.2956. View

Palmer J, Diamond A, Yeaman S, Bassendine M, Jones D . T cell responses to the putative dominant autoepitope in primary biliary cirrhosis (PBC). Clin Exp Immunol. 1999; 116(1):133-9. PMC: 1905223. DOI: 10.1046/j.1365-2249.1999.00803.x. View

Jones D, Palmer J, Yeaman S, Kirby J, Bassendine M . Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis: a mouse model of primary biliary cirrhosis. Hepatology. 1999; 30(1):65-70. DOI: 10.1002/hep.510300123. View

Ishibashi H, Shimoda S, Gershwin M . The immune response to mitochondrial autoantigens. Semin Liver Dis. 2005; 25(3):337-46. DOI: 10.1055/s-2005-916325. View

Kagaya M, Kaneko S, Ohno H, Inamura K, Kobayashi K . Cloning and characterization of the 5'-flanking region of human cytokeratin 19 gene in human cholangiocarcinoma cell line. J Hepatol. 2001; 35(4):504-11. DOI: 10.1016/s0168-8278(01)00167-2. View

10.

Matsumura S, Van de Water J, Kita H, Coppel R, Tsuji T, Yamamoto K . Contribution to antimitochondrial antibody production: cleavage of pyruvate dehydrogenase complex-E2 by apoptosis-related proteases. Hepatology. 2002; 35(1):14-22. DOI: 10.1053/jhep.2002.30280. View

11.

Wang L, Kaneko S, Kagaya M, Ohno H, Honda M, Kobayashi K . Molecular cloning, and characterization and expression of dihydrolipoamide acetyltransferase component of murine pyruvate dehydrogenase complex in bile duct cancer cells. J Gastroenterol. 2002; 37(6):449-54. DOI: 10.1007/s005350200065. View

12.

McGargill M, Mayerova D, Stefanski H, Koehn B, Parke E, Jameson S . A spontaneous CD8 T cell-dependent autoimmune disease to an antigen expressed under the human keratin 14 promoter. J Immunol. 2002; 169(4):2141-7. DOI: 10.4049/jimmunol.169.4.2141. View

13.

Jones D, Palmer J, Burt A, Walker C, Robe A, Kirby J . Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex. Hepatology. 2002; 36(3):679-86. DOI: 10.1053/jhep.2002.35067. View

14.

Roche T, Hiromasa Y, Turkan A, Gong X, Peng T, Yan X . Essential roles of lipoyl domains in the activated function and control of pyruvate dehydrogenase kinases and phosphatase isoform 1. Eur J Biochem. 2003; 270(6):1050-6. DOI: 10.1046/j.1432-1033.2003.03468.x. View

15.

Leung P, Quan C, Park O, Van de Water J, Kurth M, Nantz M . Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J Immunol. 2003; 170(10):5326-32. DOI: 10.4049/jimmunol.170.10.5326. View

16.

Selmi C, Balkwill D, Invernizzi P, Ansari A, Coppel R, Podda M . Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology. 2003; 38(5):1250-7. DOI: 10.1053/jhep.2003.50446. View

17.

Oudet P, Chambon P . Isolation of high-molecular-weight DNA from mammalian cells. Eur J Biochem. 1973; 36(1):32-8. DOI: 10.1111/j.1432-1033.1973.tb02881.x. View

18.

TISON V, Callea F, Morisi C, MANCINI A, Desmet V . Spontaneous "primary biliary cirrhosis" in rabbits. Liver. 1982; 2(2):152-61. View

19.

Church G, Gilbert W . Genomic sequencing. Proc Natl Acad Sci U S A. 1984; 81(7):1991-5. PMC: 345422. DOI: 10.1073/pnas.81.7.1991. View

20.

Ballardini G, Mirakian R, Bianchi F, Pisi E, Doniach D, Bottazzo G . Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet. 1984; 2(8410):1009-13. DOI: 10.1016/s0140-6736(84)91108-5. View